The research addresses the long-recognized poor prognosis of relatively undifferentiated cancers, suggesting that selection against differentiation and in favour of uncontrolled growth is a powerful driver of cancer progression. Goblet cells, which provide the mucous surface of the gut, are a crucial focus of this study. When present in colorectal cancers, these cancers are termed mucinous.
Key findings from the study include:
- Nearly 80 CRC-derived cell lines are classified into five categories based on the levels of MUC2 (the main mucous product of goblet cells) and TFF3 (an associated gene product).
- Identification of five distinct patterns of MUC2 and TFF3 expression, which can be easily identified in tumour specimens, allowing for a finer characterisation of CRCs concerning goblet cell differentiation.
- It was discovered that approximately 30% of all CRCs express TFF3 but not MUC2, a previously unrecognised subgroup.
- Highlighting the role of LGR5 in controlling differentiation rather than direct control of cell growth, challenging previous assumptions.
more recommended stories
Brain-Like AI Explains Relational LearningAI Unveils How the Brain Learns.
Brain’s High-Tech Fix for Blurry Vision During MovementHigh-Tech Video Optimization in Our Brain:.
Air Pollution Hurts Brain Health in Just 4 HoursAir Pollution Blurs the Mind, Impairs.
New therapies developed by Oxford experts offer online support for anxiety and post-traumatic stress disordersUrgent treatment solutions are needed for.
three key pillars to tackle antimicrobial resistance effectively — University of Oxford, Medical Sciences DivisionThe High-Level Meeting on antimicrobial resistance.
Oxford Vaccine Group marks 30 years battling ‘deadly six’ diseases with major art installation — University of Oxford, Medical Sciences DivisionThe installation was commissioned to mark.
Professor Ahmed Awarded Funding To Create World’s First Ovarian Cancer Prevention Vaccine — University of Oxford, Medical Sciences DivisionScientists at the University of Oxford,.
New research network unites Oxford University’s global fight against antimicrobial resistance — University of Oxford, Medical Sciences DivisionAntimicrobial resistance (AMR) threatens the foundation.
Typhoid vaccine trial confirms sustained protection for older children — University of Oxford, Medical Sciences DivisionThe TyVOID study, published in the Lancet, measured the.
Four Oxford researchers win prestigious Philip Leverhulme Prizes — University of Oxford, Medical Sciences DivisionOnly 30 prizes are awarded throughout.
Leave a Comment